• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TDL
Click for more information
0.00% 27.0¢

TBG DIAGNOSTICS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
TDL Appendix 4G27/03/19
TDL Annual Report to Shareholders26/03/19
TDL Full Year Statutory Accounts21/03/19
TDL Preliminary Final ReportPRICE SENSITIVE28/02/19
TDL COO Appointment/Resignation01/02/19
TDL Acquisition of Zhangsha ZhangYe Medical Laboratory CorpPRICE SENSITIVE17/12/18
TDL Half Yearly Report and AccountsPRICE SENSITIVE30/08/18
TDL Initial Director's Interest Notice30/05/18 download Created with Sketch. 387.07KB
TDL Final Director's Interest Notice30/05/18 download Created with Sketch. 340.44KB
TDL Results of Meeting28/05/18 download Created with Sketch. 302.11KB
TDL Company presentation28/05/18 download Created with Sketch. 2.95MB
TDL Notice of Annual General Meeting/Proxy Form26/04/18
TDL Director Appointment/Resignation26/04/18
TDL Appendix 4G23/03/18
TDL Annual Report to shareholders22/03/18
TDL Preliminary Final ReportPRICE SENSITIVE28/02/18
TDL Appendix 3B06/02/18
TDL Release of Shares from Escrow17/01/18
TDL JV with China SOE to meet clinical diagnostic needsPRICE SENSITIVE04/12/17
TDL Market UpdatePRICE SENSITIVE23/10/17
TDL Change of registry address notification18/10/17
TDL Half Yearly Report and AccountsPRICE SENSITIVE28/08/17
TDL ExProbe receives CE Mark and Taiwan FDA approvalPRICE SENSITIVE24/07/17
TDL ASHI accreditation for Xiamen facilityPRICE SENSITIVE19/05/17
TDL Results of Meeting12/05/17
TDL Notice of Annual General Meeting/Proxy Form11/04/17
TDL Annual Report to shareholders21/03/17
TDL Corporate Governance Statement & Appendix 4G21/03/17
TDL Exclusive Licensing AgreementPRICE SENSITIVE13/03/17
TDL Preliminary Final ReportPRICE SENSITIVE28/02/17
TDL Receipt of R&D Tax Incentive RefundPRICE SENSITIVE02/02/17
TDL Company Secretary Appointment/Resignation01/12/16
TDL AGM 2016 - Results of Meeting25/11/16
TDL 2016 AGM PresentationPRICE SENSITIVE25/11/16
TDL TBG and Omixon formalise Asia Pacific partnershipPRICE SENSITIVE15/11/16
TDL Change in Financial Year End10/11/16
TDL Notice of Annual General Meeting/Proxy Form-TDL.AX 21/10/16
TDL Change of Principal Place of Business Address-TDL.AX 13/10/16
TDL Corporate Governance Statement & Appendix 4G-TDL.AX 28/09/16
TDL Annual Report to Shareholders-TDL.AX 28/09/16
TDL Financial Report for the Year Ended 30 June 2016-TDL.AX 22/09/16
TDL Preliminary Final Report (Amended)-TDL.AX PRICE SENSITIVE31/08/16
TDL Preliminary Final Report-TDL.AX PRICE SENSITIVE31/08/16
TDL TBG Diagnostics completes strategic review-TDL.AX PRICE SENSITIVE22/08/16
TDL TBG to file Form 15-F to terminate SEC registration-TDL.AX 05/08/16
TDL TBG Diagnostics to replace exiting US auditor-TDL.AX 27/07/16
TDL Progen PG500 Series Pty Ltd Completes Phase I Trial-TDL.AX PRICE SENSITIVE22/07/16
TDL TBG Diagnostics commences HLA typing service in China-TDL.AX PRICE SENSITIVE19/07/16
TDL TBG to acquire controlling equity stake in RBC Biosciences-TDL.AX PRICE SENSITIVE29/06/16
TDL TBG Commences HLA Kit Sales with MD Anderson, Uni of Texas-TDL.AX PRICE SENSITIVE30/05/16
TDL TBG Receives Funding for HLA Typing Kit Development-TDL.AX PRICE SENSITIVE26/05/16
TDL Company Update - Board and Management Structure-TDL.AX 18/05/16
TDL Investor Presentation-TDL.AX 16/05/16
TDL Issue of Unlisted Options under Employee Share Option Plan-TDL.AX 13/05/16
TDL Change of Director's Interest Notice-TDL.AX 05/05/16
TDL Expiry of Unlisted Options - Mercer Capital15/03/16
TDL Company Update - Sale of Pharmasynth Pty LtdPRICE SENSITIVE04/03/16
TDL Half Year Report & AccountsPRICE SENSITIVE26/02/16
TDL Appointment of Edward Chang as Non-Executive Director04/02/16
TDL Change in substantial holding03/02/16
TDL Becoming a substantial holder03/02/16
TDL Appendices - 3X and 3Z02/02/16
TDL Consolidated Financial Statements for TBG Inc - Dec 201502/02/16
TDL Financial Statements for TBG Inc - Dec 2013 and 201402/02/16
TDL Securities Trading Policy02/02/16
TDL Pre-Quotation Disclosure Notice with Various Confirmations02/02/16
TDL Appendix 1A & Information Form and Checklist02/02/16
TDL Reinstatement to Official Quotation - 3 February 2016PRICE SENSITIVE02/02/16
TDL ASX Notice - Reinstatement 3 February 201602/02/16
TDL Appendix 4G
27/03/19
TDL Annual Report to Shareholders
26/03/19
TDL Full Year Statutory Accounts
21/03/19
TDL Preliminary Final Report
28/02/19PRICE SENSITIVE
TDL COO Appointment/Resignation
01/02/19
TDL Acquisition of Zhangsha ZhangYe Medical Laboratory Corp
17/12/18PRICE SENSITIVE
TDL Half Yearly Report and Accounts
30/08/18PRICE SENSITIVE
TDL Initial Director's Interest Notice
30/05/18 download Created with Sketch. 387.07KB
TDL Final Director's Interest Notice
30/05/18 download Created with Sketch. 340.44KB
TDL Results of Meeting
28/05/18 download Created with Sketch. 302.11KB
TDL Company presentation
28/05/18 download Created with Sketch. 2.95MB
TDL Notice of Annual General Meeting/Proxy Form
26/04/18
TDL Director Appointment/Resignation
26/04/18
TDL Appendix 4G
23/03/18
TDL Annual Report to shareholders
22/03/18
TDL Preliminary Final Report
28/02/18PRICE SENSITIVE
TDL Appendix 3B
06/02/18
TDL Release of Shares from Escrow
17/01/18
TDL JV with China SOE to meet clinical diagnostic needs
04/12/17PRICE SENSITIVE
TDL Market Update
23/10/17PRICE SENSITIVE
TDL Change of registry address notification
18/10/17
TDL Half Yearly Report and Accounts
28/08/17PRICE SENSITIVE
TDL ExProbe receives CE Mark and Taiwan FDA approval
24/07/17PRICE SENSITIVE
TDL ASHI accreditation for Xiamen facility
19/05/17PRICE SENSITIVE
TDL Results of Meeting
12/05/17
TDL Notice of Annual General Meeting/Proxy Form
11/04/17
TDL Annual Report to shareholders
21/03/17
TDL Corporate Governance Statement & Appendix 4G
21/03/17
TDL Exclusive Licensing Agreement
13/03/17PRICE SENSITIVE
TDL Preliminary Final Report
28/02/17PRICE SENSITIVE
TDL Receipt of R&D Tax Incentive Refund
02/02/17PRICE SENSITIVE
TDL Company Secretary Appointment/Resignation
01/12/16
TDL AGM 2016 - Results of Meeting
25/11/16
TDL 2016 AGM Presentation
25/11/16PRICE SENSITIVE
TDL TBG and Omixon formalise Asia Pacific partnership
15/11/16PRICE SENSITIVE
TDL Change in Financial Year End
10/11/16
TDL Notice of Annual General Meeting/Proxy Form-TDL.AX
21/10/16
TDL Change of Principal Place of Business Address-TDL.AX
13/10/16
TDL Corporate Governance Statement & Appendix 4G-TDL.AX
28/09/16
TDL Annual Report to Shareholders-TDL.AX
28/09/16
TDL Financial Report for the Year Ended 30 June 2016-TDL.AX
22/09/16
TDL Preliminary Final Report (Amended)-TDL.AX
31/08/16PRICE SENSITIVE
TDL Preliminary Final Report-TDL.AX
31/08/16PRICE SENSITIVE
TDL TBG Diagnostics completes strategic review-TDL.AX
22/08/16PRICE SENSITIVE
TDL TBG to file Form 15-F to terminate SEC registration-TDL.AX
05/08/16
TDL TBG Diagnostics to replace exiting US auditor-TDL.AX
27/07/16
TDL Progen PG500 Series Pty Ltd Completes Phase I Trial-TDL.AX
22/07/16PRICE SENSITIVE
TDL TBG Diagnostics commences HLA typing service in China-TDL.AX
19/07/16PRICE SENSITIVE
TDL TBG to acquire controlling equity stake in RBC Biosciences-TDL.AX
29/06/16PRICE SENSITIVE
TDL TBG Commences HLA Kit Sales with MD Anderson, Uni of Texas-TDL.AX
30/05/16PRICE SENSITIVE
TDL TBG Receives Funding for HLA Typing Kit Development-TDL.AX
26/05/16PRICE SENSITIVE
TDL Company Update - Board and Management Structure-TDL.AX
18/05/16
TDL Investor Presentation-TDL.AX
16/05/16
TDL Issue of Unlisted Options under Employee Share Option Plan-TDL.AX
13/05/16
TDL Change of Director's Interest Notice-TDL.AX
05/05/16
TDL Expiry of Unlisted Options - Mercer Capital
15/03/16
TDL Company Update - Sale of Pharmasynth Pty Ltd
04/03/16PRICE SENSITIVE
TDL Half Year Report & Accounts
26/02/16PRICE SENSITIVE
TDL Appointment of Edward Chang as Non-Executive Director
04/02/16
TDL Change in substantial holding
03/02/16
TDL Becoming a substantial holder
03/02/16
TDL Appendices - 3X and 3Z
02/02/16
TDL Consolidated Financial Statements for TBG Inc - Dec 2015
02/02/16
TDL Financial Statements for TBG Inc - Dec 2013 and 2014
02/02/16
TDL Securities Trading Policy
02/02/16
TDL Pre-Quotation Disclosure Notice with Various Confirmations
02/02/16
TDL Appendix 1A & Information Form and Checklist
02/02/16
TDL Reinstatement to Official Quotation - 3 February 2016
02/02/16PRICE SENSITIVE
TDL ASX Notice - Reinstatement 3 February 2016
02/02/16
refresh Created with Sketch. REFRESH
 

Top Stories

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.